Search
for
Sort by
Research 631–660 of 1000+
- Glycolytic Dysfunction in Granulosa Cells and Its Contribution to Metabolic Dysfunction in Polycystic Ovary Syndrome
- Disorders of ovulation
- Protective role of agomelatine via modulation of TLR4/NF-κB: NLRP3/IL-1β signaling pathways in testosterone-induced benign prostatic hyperplasia in rats
- Elevated serum chromogranin A levels are independently associated with metabolic and inflammatory disturbances in polycystic ovary syndrome
- Vitamin B6 promotes the activation of primordial follicles through the PI3K/Akt signaling pathway
- Gut–ovary axis and multiomic insights into PCOS in a DHEA-induced rat model
- What should be kept in mind when treating acne with oral contraceptives? Narrative review
- Pregnancy in a Secondary Infertile Woman with Polycystic Ovarian Syndrome (PCOS) –A Case Report
- Effects of Laparoscopic Ovarian Drilling on Restoration of Menstrual Cycles, Hormonal Profiles and Pregnancy Rate in Women with Polycystic Ovary Syndrome
- Indole-based derivatives effect on rats with polycystic ovary syndrome
- Polycystic Ovary Syndrome
- Workup and Management of Polycystic Ovary Syndrome
- Androgen Treatment in Women
- Penetration of drugs through skin, a complex rate-controlling membrane
- The eye and the skin in endocrine metabolic diseases
- Nonalcoholic fatty liver disease in young adult Egyptian women with polycystic ovary syndrome
- Multi-Approach Assessment of Albizia saponaria Bioactivity Against Dandruff-Related Bacteria and Fungi
- Efficacy and Safety of a Drinkable Nutraceutical in Premenopausal Women with Telogen Effluvium: A 6-Month, Randomized, Multicenter, Double-Blind, Placebo-Controlled Study
- A Prospective Study of the Prevalence of Nonclassical Congenital Adrenal Hyperplasia among Women Presenting with Hyperandrogenic Symptoms and Signs
- Biochemical Testing of the Thyroid: TSH is the Best and, Oftentimes, Only Test Needed – A Review for Primary Care
- Congenital Adrenal Hyperplasia
- Polycystic Ovarian Syndrome
- Significance of the polyglutamine tract polymorphism in the androgen receptor
- The safety of 52 weeks of oral DHEA therapy for postmenopausal women
- Effects of melatonin administration on mental health parameters, metabolic and genetic profiles in women with polycystic ovary syndrome: A randomized, double-blind, placebo-controlled trial
- Androgens and Antiandrogens
- Evidence for Increased 5α-Reductase Activity During Early Childhood in Daughters of Women With Polycystic Ovary Syndrome
- Hair loss and herbs for treatment
- Thyrotropin-releasing hormone and oestrogen differentially regulate prolactin and prolactin receptor expression in female human skin and hair follicles <i>in vitro</i>
- Shorter CAG repeats in the androgen receptor gene may enhance hyperandrogenicity in polycystic ovary syndrome